National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Insurance Coverage: Michigan
    Posted: 12/19/2002    Reviewed: 12/17/2008
Page Options
Print This Page
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Maintenance Rituximab for Follicular Lymphoma

Azacitidine Improves Survival in MDS

Second Stem Cell Transplant Not Helpful in Myeloma

For more information about insurance coverage of clinical trial costs, see this feature's main page: States That Require Health Plans to Cover Patient Care Costs in Clinical Trials.


Agreement: Michigan consensus agreement

Effective: February 2002

What clinical trials are covered?

Phase II and III cancer clinical trials that are sponsored or approved by any one of the following:

  • National Institutes of Health (NIH)
  • National Cancer Institute
  • U.S. Food and Drug Administration
  • U.S. Department of Defense
  • U.S. Department of Veterans Affairs
  • Centers for Medicare and Medicaid Services
  • Centers for Disease Control and Prevention

The agreement also would cover any side effects from the clinical trial treatment, including hospitalization costs.

Who is required to pay?

Private insurance plans, HMOs and the Michigan Medicaid Program.

Other key provisions:

  • Coverage for Phase I trials is under consideration.

Back to Top


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov